Skip to main navigation Skip to search Skip to main content

Development of a quantitative systems pharmacology (QSP) Model to Support Clinical Translation of adeno-associated virus (AAV) Vectorized Brain Delivery of Anti-a-Synuclein (AS) Antibody

Project: Research

Project Details

StatusFinished
Effective start/end date07/13/2010/31/22

Funding

  • AstraZeneca UK Limited: $289,920.00